Steven Cohen’s LifeMD LFMD Stock Holding History

Steven Cohen’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29,400	Closed	-$100K	–	4180
2025 Q4	$100K	Buy	+29,400	New	+$143K	﹤0.01%	3741

Other funds holding LFMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Steven Cohen's LFMD Position: Q1 2026 in Review

Steven Cohen sold out of LifeMD (LFMD) in Q1 2026, closing a stake of 399,094 shares — an estimated $1.36M sold.

Steven Cohen first reported a position in LFMD in Q3 2023 and held it in 3 quarters. The position peaked at $1.36M in Q4 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

Steven Cohen reported no remaining LifeMD position as of Q1 2026 after selling out during the quarter.
Steven Cohen sold 399,094 LifeMD shares in Q1 2026, an estimated $1.36M.
Steven Cohen first reported a position in LifeMD in Q3 2023 and held it in 3 quarters.
Steven Cohen's LifeMD position peaked at $1.36M in Q4 2025.
102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.